Skip to main content

Epratuzumab phase IIb data presented at ACR show pipeline drug had positive effect in patients suffering from moderate to severe systemic lupus erythematosus

Dokument   •   Nov 25, 2010 11:07 CET

Licens Creative Commons erkännande (?)